WASL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.100400E-01
Normal-vs-Stage2
2.185600E-01
Normal-vs-Stage3
9.377600E-01
Normal-vs-Stage4
1.387980E-01
Stage1-vs-Stage2
7.683200E-01
Stage1-vs-Stage3
5.192100E-02
Stage1-vs-Stage4
3.117200E-01
Stage2-vs-Stage3
1.859750E-01
Stage2-vs-Stage4
1.060400E-01
Stage3-vs-Stage4
8.230300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.352200E-01
Normal-vs-AfricanAmerican
3.043000E-01
Normal-vs-Asian
4.241000E-01
Caucasian-vs-AfricanAmerican
5.776600E-01
Caucasian-vs-Asian
6.646200E-01
AfricanAmerican-vs-Asian
5.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.138000E-01
Normal-vs-Female
2.571000E-01
Male-vs-Female
5.417600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.397600E-01
Normal-vs-Age(41-60Yrs)
1.056960E-01
Normal-vs-Age(61-80Yrs)
3.271000E-01
Normal-vs-Age(81-100Yrs)
3.326400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.491800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.844600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.706800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.085550E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.781800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.969800E-01
Normal-vs-Daily Drinker
3.776000E-01
Normal-vs-Weekly Drinker
4.030600E-01
Normal-vs-Occasional Drinker
1.066630E-01
Normal-vs-Social Drinker
2.432400E-01
Non Drinker-vs-Daily Drinker
9.196200E-01
Non Drinker-vs-Weekly Drinker
6.685000E-01
Non Drinker-vs-Occasional Drinker
2.797800E-01
Non Drinker-vs-Social Drinker
1.939250E-01
Daily Drinker-vs-Weekly Drinker
7.714600E-01
Daily Drinker-vs-Occasional Drinker
4.217200E-01
Daily Drinker-vs-Social Drinker
2.055200E-01
Weekly Drinker-vs-Occasional Drinker
7.550200E-01
Weekly Drinker-vs-Social Drinker
4.243800E-01
Occasional Drinker-vs-Social Drinker
4.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.251900E-02
Normal-vs-Grade 2
1.039710E-03
Normal-vs-Grade 3
1.261650E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.189000E-01
Grade 1-vs-Grade 3
3.377400E-01
Grade 1-vs-Grade 4
8.251900E-02
Grade 2-vs-Grade 3
5.767200E-01
Grade 2-vs-Grade 4
1.039710E-03
Grade 3-vs-Grade 4
1.261650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.828800E-01
Normal-vs-NonDiabetic
2.091400E-01
Diabetic-vs-NonDiabetic
4.408800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.412770E-01
Normal-vs-NoPancreatitis
2.509000E-01
Pancreatitis-vs-NoPancreatitis
8.664600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.714400E-01
Normal-vs-N1
2.212200E-01
N0-vs-N1
8.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.269600E-01
Normal-vs-TP53-NonMutant
3.225800E-01
TP53-Mutant-vs-TP53-NonMutant
3.163600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
